Emergent BioSolutions Inc. — Director's Dealing 2021

Mar 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2021-03-01

Reporting Person: Havey Adam (EVP, Business Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-01	Common Stock	M	17134	$30.63	Acquired	55324	Direct
2021-03-01	Common Stock	S	17134	$99.62	Disposed	38190	Direct
2021-03-01	Common Stock	M	20145	$49.64	Acquired	58335	Direct
2021-03-01	Common Stock	S	20145	$99.02	Disposed	38190	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-01	Employee Stock Options (Right to Buy)	$30.63	M	17134	Disposed	2024-02-27	Common Stock (17134.0)	Direct
2021-03-01	Employee Stock Options (Right to Buy)	$49.64	M	20145	Disposed	2025-02-26	Common Stock (20145.0)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.

F2: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $98.05 to $100.25.

F3: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $98.01 to $99.99.

F4: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.